Danaher Corporation (NYSE:DHR) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, Danaher Corporation (NYSE:DHR) announced an agreement to acquire Masimo ...

Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for the “Madison Large Cap Fund”. A copy of the letter can be downloaded here. In the fourth quarter, the S ...

Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: ...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, ...

Feb 16 (Reuters) - Life sciences firm Danaher is closing in on a nearly $10 billion deal to acquire pulse oximeter maker ...

On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue increased by 0.5%, compared to ...

Danaher has struck an almost $10bn deal to buy patient monitoring company Masimo, two years after an activist investor ...

On Tuesday, Danaher Corp's DHR second quarter sales decreased 3% year-over-year to $$5.743 billion, beating the consensus of $5.59 billion. Non-GAAP core revenue decreased by 3.5%, compared to the ...